🧬 Tier 2: Due Diligence Deep Dive

750,00 

€750 / hour (Minimum 3 hours recommended)
Detailed clinical, regulatory & market analysis.

Best for:
Institutional investors preparing for a funding round, catalyst trade, or partnership evaluation.

What’s Included:

  • Thorough review of trials, endpoints, and regulatory path

  • MoA differentiation & competitor risk mapping

  • Sentiment from top-tier thought leaders & investigators

  • Timeline of catalysts (12–18 months outlook)

  • 2–3 page written briefing document

Next Step:
Once payment is complete, we’ll reach out directly to align on your target asset, timeframe, and key questions.

A detailed, data-backed consultation designed to assess biotech assets through clinical, regulatory, and market lenses—ideal for investors preparing for key decisions.

Reviews

There are no reviews yet.

Be the first to review “🧬 Tier 2: Due Diligence Deep Dive”

Your email address will not be published. Required fields are marked *

Scroll to Top
My cart
Your cart is empty.

Looks like you haven't made a choice yet.